Development of a new analytical method for determination of related components in nateglinide

Chromatographia

Volumn 67, Issue 7-8, 2008, Pages 639-645

  Madhavi, A ^a,b   Reddy, G S ^a   Suryanarayana, M V ^a   Naidu, A ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Column liquid chromatography; Forced degradation; Nateglinide; Validation and stability indicating

Indexed keywords

NATEGLINIDE;

ARTICLE; DRUG ANALYSIS; DRUG HYDROLYSIS; DRUG OXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHOTOLYSIS; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY;

EID: 41849135354     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0548-z     Document Type: Article

References (19)

1. Fujitani S, Okazaki K, Yada T (1997) Br J Pharmacol 120:1191-1198
2. Karara AH, Dunning BE, McLeod JF (1999) J Clin Pharmacol 39:172-179
3. Dunn CJ, Faulds D (2000) Drugs 60:607-615
4. Fujitani S, Yada T (1994) Endocrinology 134:1395-1400
5. Yoshikazu N, Hiroyui A, Makoto I, Kazutoshi T, Kazuo H, Shoj T (1999) Yakuri to Chiryo 27:1177-1203
6. Keilson L, Mather S, Walter YH, Subramanian S, Mcleod JF (2000) J Clin Endocrinol.Metab 85:1081-1086
7. Sankalia JM, Sankalia MG, Sutariya VB, Mashru RC (2007) J Pharm Biomed Anal 44:196-204
8. Hongyuan Yan, Gengliang Yang, Fengxia Qiao, Yi Chen (2004) J Pharm Biomed Anal 36:169-174
9. Bauer S, Störmer E, Kirchheiner J, Michael C, Brockmöller J, Roots I (2003) J Pharm Biomed Anal 31:551-555
10. Ono I, Matsuda K, Kanno S (1997) J Chromatogr B 692:397-404
11. Ono I, Matsuda K, Kanno S (1996) J Chromatogr B Biomed Sci Appl 678:384-387
12. Malli D, Gikas E, Vavagiannis A, Kazanis M, Daniilides K, Gennimata D, Panderi I (2007) Anal Chim Acta 599:143-150
13. ICH Stability Testing of New Drug Substances and Products Q1A (R2) (2003) International Conference on Harmonization, IFPMA, Geneva
14. Singh S, Bakshi M (2000) Pharm Tech On-line 24:1-14
15. ICH, Photo Stability Testing of New Drug Substances and Products Q1B (1996) International Conference on Harmonization, IFPMA, Geneva
16. Bakshi M, Singh S, Pharm J (2002) Biomed Anal 28:1011-1040
17. Singh S, Singh B, Bahuguna R, Wadhwa L, Saxena R (2006) J Pharm Biomed Anal 41:1037-1040
18. Carstensen JT, Rhodes CT (eds) (2000) Drug stability principles and practices, 3rd edn
19. ICH Guidelines on Validation of Analytical Procedures: Text and Methodology Q2 (R1) (1995): FDA: Published in the Federal Register, vol 60, p 11260, March 1, 1995